Skip to content

News archive

  • In September, Daniel Pacurar and Matt Baida visited Kiruna to collect moss samples. A primer mixture will be produced using this moss and hydro-seeded at two separate test locations.

    Eco-innovation from Umeå breaking new ground for the mining industry

    Restoring natural ecosystems in mining disturbed landscapes is a crucial yet complex process. A groundbreaking Swedish initiative, which employs moss to accelerate this restoration, is now being heralded as a potential game changer for the global mining industry. The mining companies Boliden, Copperstone Resources, LKAB, and Talga are all participating in the ‘re:moss’ project

  • Research and expert support is provided at FOI in Umeå for chemical, biological, and radioactive substances. Susanne W Lindström is Head of the Chemical Threat and Effect Assesments Unit in Umeå.

    FOI in Umeå launches recruitment drive in response to global security concerns

    The Swedish Defence Research Agency (FOI) is set to significantly expand its operations in Umeå this spring after announcing plans to hire around 20 new employees to the CBRN Defence and Security department. Global developments mean Sweden needs to strengthen its national defence capability – with long-term research provided by FOI playing an important role.

  • "We are confident that rotating bed reactors will be pivotal in successfully remedying PFAS-contaminated sites" says Emil Byström, CEO of SpinChem about their contribution to the Beat-PFAS project.

    SpinChem plays crucial role in SEK 19 million PFAS-project

    The Umeå based company SpinChem AB is set to play a crucial role in the "Beat-PFAS project", funded by Formas, a Swedish government research council dedicated to sustainable development, with a grant of SEK 19.9 million. The project, led by Professor Jurate Kumpiene, aims to develop an effective solution for removing and destroying PFAS from contaminated soil and water.

  • UmanDiagnostics hosted the last QA network meeting. "While often overlooked, the QA function is an indispensable aspect for success in our sector", remarks Peter Jacobsson, operations coordinator at UBI.

    Quality Assurance in Life science Umeå gets a boost from new network

    The response was overwhelming when Umeå Biotech Incubator launched the Quality Assurance network in Umeå this spring. The QA network brings together around 20 representatives from Life Science Umeå to exchange experiences and tackle the industry's increasingly complex quality requirements.

  • Niklas Norgren, VP and Managing director at UmanDiagnostics, with newly recruited Maria Hörnberg and Ronja Lindgren. With the autumn's new hires, the in vitro diagnostics company has gone from being a micro to a small business.

    UmanDiagnostics continues to expand with recruitment of two new members of staff

    The in vitro diagnostics company UmanDiagnostics has gone from being a micro business to a small business. The company specializes in nerve injury markers and the Neurofilament light protein (NFL), which makes it easier to find and diagnose neurological diseases such as Multiple Sclerosis, ALS, and Alzheimer's disease.

  • The founders of HiloProbe from the left: Lina Olsson, CEO, Marie-Louise Hammarström, R&D specialist, Anne Israelsson, Product specialist, Gudrun Lindmark, Clinical specialist, and Sten Hammarström, Scientific officer.

    New study confirms HiloProbe's ColoNode kit improves colon cancer diagnostics

    Swedish biotech company HiloProbe has reached a significant milestone after the results of a prospective multicenter study conducted in collaboration with Umeå University and eight Swedish hospitals were published in the International Journal of Cancer. The study results show that HiloProbe's ColoNode kit improves colon cancer diagnostics and can help more patients survive.

  • Mucocort secures European patent and strengthens collaboration with Aurena Laboratories

    Mucocort secures European patent and strengthens collaboration with Aurena Laboratories

    Swedish MedTech company Mucocort plans to launch a mucosal self-absorbing patch for pain relief in people suffering from aphthous stomatitis (mouth ulcers). The interest in Mucocort patch technology has increased after the approval of a European patent. Further, the Mucocort AB minority stakeholder Aurena Laboratories steps up with additional capital and increases its ownership.

  • "We are delighted they chose us when they wanted to build a brand new, modern hospital”, says Erik Lindström, CEO of Medicvent about the assignment at Högsbo Närsjukhus.

    Swedish MedTech company Medicvent strenghtens market position with new prestigious assignment

    Umeå-based Medicvent has been awarded a new prestigious assignment to deliver central systems for waste gas/diathermy and its unique double mask system used in anesthesia to Högsbo Regional Hospital, which will be inaugurated in Gothenburg in 2024. "Things are going well both in Sweden and abroad. We also have a couple of new markets that we are hoping to supply", says CEO Erik Lindström.

  • "We know that there is huge potential in Umeå, both within MedTech and life science in general" says Robert Tönhardt, Life Science Director at Prevas. Photo: Prevas

    Life science consulting company seeks manager for new offices in Umeå

    Technology consulting company Prevas is looking to hire a Business Unit Manager for its new offices in the city. "We know that there is huge potential in Umeå, both within MedTech and life science in general", says Robert Tönhard, Life Science Director at Prevas.

  • Pernilla Isberg, Director Operations, AZ BioVentureHub at AstraZeneca, with Tobias Tovedal, business coach at UBI.

    The AstraZeneca non-profit mentorship program giving expert advice to UBI startups

    The AstraZeneca Exchange Nordic mentorship program provides expert advice to Nordic life science startups and entrepreneurs. For Umeå Biotech Incubator (UBI) the program has proven to be an invaluable tool for the startups it coaches - offering a range of advice from market and needs analysis to more specific technical questions.

Show more